Betta Pharmaceuticals Co., Ltd.
300558 SHE







Weekly Report
Betta Pharmaceuticals Co., Ltd. closed at 70.2000 (-1.13% WoW) . Data window ends Mon, 15 Sep 2025.
How to read this โ Price slope is upward, indicating persistent buying over the window. Volume trend diverges from price โ watch for fatigue or rotation. Returns are positively correlated with volume โ strength tends to arrive on higher activity. Constructive MA stack supports the up-drift; pullbacks may find support at the 8โ13 week region. Price holds above key averages, indicating constructive participation.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm. Because liquidity isnโt confirming, prefer evidence of fresh demand before chasing moves.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Gauge is elevated but momentum is rolling over; topping risk is rising. Notable breakdown from โฅ0.80 weakens trend quality.
Stay alert: protect gains or seek confirmation before adding risk.
Price is above fair value; upside may be capped without catalysts.
Conclusion
Negative setup. โ โ โโโ confidence. Price window: 6. Trend: Uptrend at Risk; gauge 79. In combination, liquidity diverges from price.
- Price holds above 8w & 26w averages
- Constructive moving-average stack
- High-level but rolling over (topping risk)
- Momentum is weak/falling
- Liquidity diverges from price
- Sellers active at elevated levels (distribution)
Why: Price window 6.28% over 8w. Close is -4.03% below the prior-window high. Volume trend falling. Liquidity divergence with price. Trend state uptrend at risk. High-regime (0.80โ1.00) downticks 3/5 (60.0%) โข Distributing. MA stack constructive. Momentum neutral and falling. Valuation limited upside without catalysts.
Tip: Most metrics include a hover tooltip where they appear in the report.